Literature DB >> 11593428

Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis.

I Alevizos1, M Mahadevappa, X Zhang, H Ohyama, Y Kohno, M Posner, G T Gallagher, M Varvares, D Cohen, D Kim, R Kent, R B Donoff, R Todd, C M Yung, J A Warrington, D T Wong.   

Abstract

Large scale gene expression profiling was carried out on laser capture microdissected (LCM) tumor and normal oral epithelial cells and analysed on high-density oligonucleotide microarrays. About 600 genes were found to be oral cancer associated. These oral cancer associated genes include oncogenes, tumor suppressors, transcription factors, xenobiotic enzymes, metastatic proteins, differentiation markers, and genes that have not been implicated in oral cancer. The database created provides a verifiable global profile of gene expression during oral carcinogenesis, revealing the potential role of known genes as well as genes that have not been previously implicated in oral cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11593428     DOI: 10.1038/sj.onc.1204685

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  54 in total

1.  Accurate and reproducible gene expression profiles from laser capture microdissection, transcript amplification, and high density oligonucleotide microarray analysis.

Authors:  Veronica Luzzi; Mamatha Mahadevappa; Rajiv Raja; Janet A Warrington; Mark A Watson
Journal:  J Mol Diagn       Date:  2003-02       Impact factor: 5.568

2.  Role of microarray in cancer diagnosis.

Authors:  Hoguen Kim
Journal:  Cancer Res Treat       Date:  2004-02-29       Impact factor: 4.679

3.  Gene expression analysis of SCC tumor cells in muscle tissue.

Authors:  Walter Hundt; Esther L Yuh; Mykhaylo Burbelko; Andreas Kiessling; Mark D Bednarski; Silke Steinbach
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-10-15       Impact factor: 2.503

4.  Reliability and reproducibility of gene expression measurements using amplified RNA from laser-microdissected primary breast tissue with oligonucleotide arrays.

Authors:  Chialin King; Ning Guo; Garrett M Frampton; Norman P Gerry; Marc E Lenburg; Carol L Rosenberg
Journal:  J Mol Diagn       Date:  2005-02       Impact factor: 5.568

Review 5.  Genomic screening of head and neck cancer and its implications for therapy planning.

Authors:  Jan Akervall
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-03-31       Impact factor: 2.503

6.  Whole genome expression profiling in chewing-tobacco-associated oral cancers: a pilot study.

Authors:  Sanjukta Chakrabarti; Shaleen Multani; Jyoti Dabholkar; Dhananjaya Saranath
Journal:  Med Oncol       Date:  2015-02-07       Impact factor: 3.064

Review 7.  Dysregulated molecular networks in head and neck carcinogenesis.

Authors:  Alfredo A Molinolo; Panomwat Amornphimoltham; Cristiane H Squarize; Rogerio M Castilho; Vyomesh Patel; J Silvio Gutkind
Journal:  Oral Oncol       Date:  2008-09-19       Impact factor: 5.337

8.  Oral Health May Affect the Performance of mRNA-Based Saliva Biomarkers for Oral Squamous Cell Cancer.

Authors:  József Horváth; Adrien Szabó; Ildikó Tar; Balázs Dezső; Csongor Kiss; Ildikó Márton; Beáta Scholtz
Journal:  Pathol Oncol Res       Date:  2017-08-31       Impact factor: 3.201

9.  Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MS.

Authors:  Lang-Ming Chi; Chien-Wei Lee; Kai-Ping Chang; Sheng-Po Hao; Hang-Mao Lee; Ying Liang; Chuen Hsueh; Chia-Jung Yu; I-Neng Lee; Yin-Ju Chang; Shih-Ying Lee; Yuan-Ming Yeh; Yu-Sun Chang; Kun-Yi Chien; Jau-Song Yu
Journal:  Mol Cell Proteomics       Date:  2009-03-18       Impact factor: 5.911

Review 10.  Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S.

Authors:  J D Mitchell; J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  2009-06-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.